Practice Guidelines College of Cardiology Foundation/American Heart Association Task Force on Atrial Fibrillation (Updating the 2006 Guideline): A Report of the American 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With

Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online 72514 Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX DOI: 10.1161/CIR.0b013e3181fa3cf4 published online Dec 20, 2010; Circulation Slotwiner, Warren M. Jackman, William G. Stevenson and Cynthia M. Tracy Lowe, N.A. Mark Estes, III, Richard L. Page, Michael D. Ezekowitz, David J. L. Samuel Wann, Anne B. Curtis, Craig T. January, Kenneth A. Ellenbogen, James E. Practice Guidelines College of Cardiology Foundation/American Heart Association Task Force on Atrial Fibrillation (Updating the 2006 Guideline): A Report of the American 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With http://circ.ahajournals.org located on the World Wide Web at: The online version of this article, along with updated information and services, is

[1]  J. Le Heuzey,et al.  A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study , 2010, Journal of cardiovascular electrophysiology.

[2]  Otto Kamp,et al.  Lenient versus strict rate control in patients with atrial fibrillation. , 2010, The New England journal of medicine.

[3]  C. Tondo,et al.  Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  Burr Hall,et al.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.

[5]  Elia Biganzoli,et al.  Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation. Arrhythmia and electrophysiology.

[6]  A. Rabinstein.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2010 .

[7]  D. Mark,et al.  Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank. , 2010, American heart journal.

[8]  Leon Poller,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[9]  S. Connolly,et al.  Effect of dronedarone on cardiovascular events in atrial fibrillation. , 2009, The New England journal of medicine.

[10]  V. Hasselblad,et al.  Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized, Controlled Trials , 2009, Circulation. Arrhythmia and electrophysiology.

[11]  S. Connolly,et al.  Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter , 2009, Circulation.

[12]  V. Hasselblad,et al.  Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. , 2009, Journal of the American College of Cardiology.

[13]  J. Lau,et al.  Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation , 2009, Annals of Internal Medicine.

[14]  Matthew R. Reynolds,et al.  Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses , 2009, Circulation. Arrhythmia and electrophysiology.

[15]  David J Cohen,et al.  Cost-Effectiveness of Radiofrequency Catheter Ablation Compared With Antiarrhythmic Drug Therapy for Paroxysmal Atrial Fibrillation , 2009, Circulation. Arrhythmia and electrophysiology.

[16]  C. Grines,et al.  Combining antiplatelet and anticoagulant therapies. , 2009, Journal of the American College of Cardiology.

[17]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[18]  W. Pikto-Pietkiewicz.  [The effect of dronedarone on the frequency of cardiovascular events in patients with atrial fibrillation - ATHENA studies]. , 2009, Kardiologia polska.

[19]  A. Waldo.  Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) study , 2009 .

[20]  D. Callans.  Apples and oranges: comparing antiarrhythmic drugs and catheter ablation for treatment of atrial fibrillation. , 2008, Circulation.

[21]  David O. Martin,et al.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.

[22]  A. Camm,et al.  Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .

[23]  J. McMurray,et al.  Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.

[24]  John V. Wylie,et al.  Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. , 2008, Archives of internal medicine.

[25]  A. Waldo.  Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation , 2008 .

[26]  E. Aliot,et al.  Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. , 2007, The New England journal of medicine.

[27]  J. Ruskin,et al.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.

[28]  S. Laffite,et al.  Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties. , 2007, Journal of the American College of Cardiology.

[29]  I. Katedra.  Commentary to the article: Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 2006; 48: 2340-7. , 2007 .

[30]  V. Santinelli,et al.  A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.

[31]  C. Tondo,et al.  Pulmonary Vein Vestibule Ablation for the Control of Atrial Fibrillation in Patients with Impaired Left Ventricular Function , 2006, Pacing and clinical electrophysiology : PACE.

[32]  Samuel Wann,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ , 2006, European heart journal.

[33]  C. Pandozi,et al.  Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation: a prospective and randomized study. , 2006, Journal of the American College of Cardiology.

[34]  M. Pfeffer,et al.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial , 2006, The Lancet.

[35]  M. Coceani,et al.  Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias , 2006, Journal of cardiovascular electrophysiology.

[36]  Frank Bogun,et al.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation. , 2006, The New England journal of medicine.

[37]  Antonio De Simone,et al.  Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). , 2006, European heart journal.

[38]  Prashanthan Sanders,et al.  Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias , 2005, Journal of cardiovascular electrophysiology.

[39]  Christopher Piorkowski,et al.  Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence , 2005, Circulation.

[40]  Claus Schmitt,et al.  Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation: A Randomized Comparison Between 2 Current Ablation Strategies , 2005, Circulation.

[41]  Mandeep Bhargava,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[42]  A. De Simone,et al.  Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. , 2005, Journal of the American College of Cardiology.

[43]  V. Santinelli,et al.  Transcatheter radiofrequency ablation of atrial fibrillation in patients with mitral valve prostheses and enlarged atria: safety, feasibility, and efficacy. , 2005, Journal of the American College of Cardiology.

[44]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[45]  G. Breithardt,et al.  Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. , 2004, European heart journal.

[46]  Brian Olshansky,et al.  The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[47]  David O. Martin,et al.  Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. , 2004, Journal of the American College of Cardiology.

[48]  G. Kay,et al.  Design and Implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) Clinical Trial , 2004, Journal of Interventional Cardiac Electrophysiology.

[49]  Burr Hall,et al.  Catheter Ablation for Paroxysmal Atrial Fibrillation: Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation , 2003, Circulation.

[50]  A. Capucci,et al.  Dronedarone for prevention of atrial fibrillation: a dose-ranging study. , 2003, European heart journal.

[51]  Ottavio Alfieri,et al.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. , 2003, Journal of the American College of Cardiology.

[52]  O. Alfieri,et al.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation , 2003 .

[53]  M. Josephson,et al.  Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter. , 2003, The American journal of cardiology.

[54]  Gabriele Vicedomini,et al.  Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia A New Anatomic Approach for Curing Atrial Fibrillation , 2000 .

[55]  M. Glanz,et al.  The Sharer , 2000, Annals of Internal Medicine.

[56]  J. Reiffel.  Inpatient versus outpatient antiarrhythmic drug initiation: safety and cost-effectiveness issues. , 2000, Current opinion in cardiology.

[57]  J. Knottnerus,et al.  Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin , 1999, BMJ.

[58]  V. Barriales,et al.  Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group. , 1999, American heart journal.

[59]  P. Petersen,et al.  Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. , 1999, Archives of internal medicine.

[60]  M. Josephson,et al.  Evaluation of outpatient initiation of antiarrhythmic drug therapy in patients reverting to sinus rhythm after an episode of atrial fibrillation. , 1999, The American journal of cardiology.

[61]  G. Kay,et al.  Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial. DAPPAF Phase 1 Investigators. , 1998, Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing.

[62]  E. Antman,et al.  Risk of Initiating Antiarrhythmic Drug Therapy for Atrial Fibrillation in Patients Admitted to a University Hospital , 1997, Annals of Internal Medicine.

[63]  W. J. Hamilton,et al.  Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.

[64]  T. Binder,et al.  Diurnal variation of ventricular response to atrial fibrillation in patients with advanced heart failure. , 1995, American heart journal.

[65]  P. Kligfield,et al.  Variability of the ventricular response in atrial fibrillation and prognosis in chronic nonischemic mitral regurgitation. , 1994, The American journal of cardiology.

[66]  Stroke Investigators.  Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study , 1994, The Lancet.

[67]  Eaft Study Group.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.

[68]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[69]  S M Nazarian,et al.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.

[70]  C Warlow,et al.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[71]  M. Laakso,et al.  The European Stroke Prevention Study , 1991, Neurology.

[72]  M Gent,et al.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.

[73]  Palle Petersen,et al.  PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[74]  S. Sandhu,et al.  Optimal sampling interval to estimate heart rate at rest and during exercise in atrial fibrillation. , 1989, The American journal of cardiology.